Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ATIS is on the move! -- Ignore unavailable to you. Want to Upgrade?

To: Harry D. Kramer who wrote (1159)	11/15/1997 1:08:00 AM
From: Marshall Teitelbaum	Respond to of 2205

Harry, Thanks for mentioning...actually it had been in post #1145, along with another tidbit I still find interesting...the fact that benvenuto and naughton have shares by way of loans from the company for some pretty hefty amounts, which start coming due if memory serves, between may and july...forget which was for which. I haven't seen any insider selling to speak of since I have been following the company more closely. Also of importance is this past wednesday dermagraft launch in Finland, although for some reason this only showed up with S&N, rather than including ATIS in the release...although for the european countries, it is S&N taking responsibility for the launches and marketing. In addition, keep you eye on tuesday next week(18th), as the confirmatory study data should be presented in detail for the first time, by Gail Naughton at a symposium. Where across the pond are you located anyway, Harry? Maybe you can do some extra spying on S&N for us? :) Take care, Marshall